CaliPharms Humboldt County Medical Cannabis Facility

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
47
CaliPharms Humboldt County Medical Cannabis Facility Reports Full Production

RIVERSIDE, CA--(Marketwired - Jul 13, 2017) - CaliPharms, Inc. ( OTC PINK : KGET ), a Company operating in the California Medicinal Cannabis industry, publicly trading under the OTC Markets symbol "KGET," continues its successful production of medicinal cannabis in Humboldt County.

CaliPharms' subsidiary, Pacific Cannabis Grower's (PCG) grow season is in full swing. All of the 10,000 sq/ft of canopy space is being utilized by its highly desirable strain line up. The plants are healthy and being tended to daily by expert growers. PCG is expecting to harvest between 1500-2250 lbs of cannabis flower before this year. This projected income will allow us to acquire commercial greenhouses and cultivation equipment to increase our yield and quality, paving the way for multiple harvests throughout the year. Management is very excited that everything is progressing as planned.

On May 15, 2017, Pacific Cannabis Growers, Inc. was issued a 10,000 sq-ft Mixed-light grow permit by the County of Humboldt. This was the 21st commercial cannabis permit awarded by the county of Humboldt out of nearly 2,400 applicants.

President of CaliPharms, Inc. Bo Linton stated, "All the hard work and planning is now in full effect. Our professional staff at PCG has the medical cannabis plants growing healthy. Our team will continue to monitor and manage the crops and we expect great results in our first harvests and then many more to come."

Linton further stated, "CaliPharms continues to seek strategic acquisitions as well as adding new management team to our staff as we grow. Initially we want to streamline all of our processes and expand when we are ready."

Please see our company videos: Company Vision  https://youtu.be/UNjImyPw1Oc Business Vision  https://youtu.be/TCTrG_EC4VU

For up to date information on the company please follow us @ facebook.com/CaliPharms twitter.com/CaliPharms

About CaliPharms, Inc.

CaliPharms, Inc., trading under the symbol (KGET) which trades under its former name "Kleangas Energy Technologies, Inc." is a medical marijuana-cannabis business. The Company operates through its 51% owned subsidiary County Junction Farms, Inc., and Pacific Cannabis Growers, Inc. within the State of California. The Company currently is focused within the medical marijuana-cannabis industry. The second tier of development for the company will be to expand into other sectors that support the legalized cannabis industry. The company intends to expand its operations as the laws for each individual State change and allow.

About Country Junction Farms, Inc.

Founded in 2010, Country Junction Farms is a fully permitted cultivator of medical cannabis within the State of California.

About Pacific Cannabis Growers, Inc.

PCG is a medical cannabis farm that is currently in the process of permitting land in Humboldt County for cultivation of medical cannabis. PCG currently is fully funded for one year of cultivation.

Safe Harbor Statement:

Safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as CaliPharms or KGET or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Investment into a microcap company is a high risk investment and it should only be considered if you are able to afford a total loss of the investment. Laws and Regulations of Marijuana are currently in direct contradiction between California and Federal Law and these factors should be a part of your consideration when making an investment into KGET.

Company Contact: CaliPharms, Inc. (KGET) www.CaliPharmsInc.com facebook.com/CaliPharms twitter.com/CaliPharms Telephone 1-949-800-6645 Email: info@CaliPharmsInc.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 210

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 129

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 42

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 241

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 343

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading

Top 5 Most Recently Viewed Articles

Anticipating NeuroOne's Q2 Financial Insights and Growth Strategies

Updated Category News Views 124

NeuroOne Prepares to Release Second Quarter Fiscal Financial Results EDEN PRAIRIE, Minn. — NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) is set to unveil its financial performance for the fiscal second quarter. The reporting period ended on March 31, and the results will be publicized before market activities commence on May 13. This is an exciting time for...

Continue Reading
FNB's Grand Plan for Ultra-Rich Wealth Clients

Updated Category News Views 79

FNB Corporation's New Strategy Sparks Interest Ah, the ever-competitive world of financial services targets the well-heeled once again. FNB Corporation (NYSE: FNB), headquartered in Pittsburgh, is rolling up its sleeves to offer something new for ultra-high-net-worth clientele. Outside Wall Street's dizzying chaos, this quiet yet aggressive move seems to signal they're up...

Continue Reading
Brazil Stock Market Trends and Key Indicators Update

Updated Category News Views 300

Brazil Stock Market Overview Recently, Brazil's stock market showed signs of decline, particularly on a Thursday when the Bovespa index dropped by 0.79%, reaching a new three-month low. This downturn was primarily driven by losses in critical sectors such as Public Utilities, Electric Power, and Real Estate. Investors and market analysts closely monitor these trends as...

Continue Reading
NEXN Stock Reaches New Heights Amid Positive Market Trends

Updated Category News Views 159

NEXN Stock Hits New Milestone NEXN stock has recently hit a significant milestone, reaching a price of $8.34. This impressive peak is not just a reflection of the company’s strong performance but also highlights a period filled with optimism in the market. With investors closely monitoring the stock's path, this new high may point to a potential sustained upward trend...

Continue Reading
Total Voting Rights Update from PayPoint Plc

Updated Category News Views 108

Understanding PayPoint Plc's Total Voting Rights PayPoint Plc has recently provided an update regarding its voting rights and share capital, which is crucial information for shareholders and those interested in the company. Total Share Capital Information As of August 31, 2024, PayPoint Plc's share capital consists of 72,342,171 ordinary shares, each valued at 1/3 pence....

Continue Reading